Pharmaceutical Supplies Procurement for Indian Army Healthcare

Work Description - NA

This tender, initiated by the Department of Military Affairs under the Ministry of Defence, represents an urgent requirement for a diverse range of pharmaceutical supplies essential for the Indian Army's operational readiness and healthcare provision. The bid, with number GEM/2026/B/7859803, is open for submissions from July 31, 2026, 1:20 PM, and closes on August 10, 2026, at 2:00 PM. The scope of supply encompasses a comprehensive list of medications including POTASSIUM CHLORIDE LIQUID 20%, ANTI-PHLEBITIS CREAM (HEPARIN 50 IU + BENZYL NICOTINATE), SODIUM CHLORIDE 3% SOLUTION, COLCHICINE 0.5 MG TABLETS, LEVOSALBUTAMOL SULPHATE 1.25 MG RESPULES, a combination topical anesthetic (LIGNOCAINE 2.5% + PRILOCAINE 2.5% TUBE), LEVOFLOXACIN 500MG INJECTION and TABLETS, COLISTIMETHATE SODIUM 1 MILLION IU INJECTION, CALCIUM ACETATE 500 MG TABLETS, HALOPERIDOL 5MG TABLETS, COUGH LOZENGES, and FRUSEMIDE 10 MG/ML INJECTION. The total estimated quantity for these critical items is 25,060 units. Suppliers are expected to provide high-quality, compliant pharmaceutical products that meet stringent military standards, ensuring the health and well-being of service personnel.